Orchestra BioMed Holdings (OBIO) Change in Inventory (2022 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Change in Inventory came in at -$33000.0 in Q1 2026, up 13.16% year-on-year from -$29162.8 in Q1 2025, and up 40.0% on a QoQ basis from -$55000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Change in Inventory (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 5 years of Change in Inventory data on file, last reported at -$33000.0 in Q1 2026.
- On a quarterly basis, Change in Inventory rose 13.16% year-over-year to -$33000.0 in Q1 2026; TTM through Mar 2026 was $142000.0, a 576.19% increase from a year earlier, with the FY2025 full-year figure at $137000.0, up 389.29% from the prior year.
- Change in Inventory for Q1 2026 stood at -$33000.0, up from -$55000.0 in the prior quarter.
- Over the last five years, Change in Inventory for OBIO reached as high as $197000.0 in Q3 2022 and fell as low as -$60000.0 in Q4 2024.
- Historically, Change in Inventory has averaged $12294.1 across 5 years, with a median of -$36000.0 in 2022.
- On a YoY basis, Change in Inventory climbed as much as 500.0% in 2024 and fell as far as 850.0% in 2024.
- Year by year, Change in Inventory stood at -$54000.0 in 2022, then soared by 114.81% to $8000.0 in 2023, then plunged by 850.0% to -$60000.0 in 2024, then increased by 8.33% to -$55000.0 in 2025, then soared by 40.0% to -$33000.0 in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were -$33000.0 in Q1 2026, -$55000.0 in Q4 2025, and $181000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 | -33,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33,000.00 |
| Mar 31, 2026 | -33,000.00 |
| Dec 31, 2025 | -55,000.00 |
| Dec 31, 2025 | -55,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Mar 31, 2025 | -38,000.00 |
| Dec 31, 2024 | -60,000.00 |
| Dec 31, 2024 | -60,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Jun 30, 2024 | -45,000.00 |
| Jun 30, 2024 | -45,000.00 |
| Mar 31, 2024 | -31,000.00 |
| Mar 31, 2024 | -31,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |